Human Coagulation Factor Ⅷ (Hualan Biological Engineering)

人凝血因子VIII（华兰生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Coagulation Factor Ⅷ (Hualan Biological Engineering)
Drug Alias NameFactor VIII (intravenous) (Hualan Biological Engineering)Kangsiping康斯平
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia ABlood Coagulation Disorders
Global Approved IndicationsHemophilia ABlood Coagulation Disorders
Approved Indications in ChinaHemophilia ABlood Coagulation Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Ankang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Engineering Inc
Inactive CompaniesHualan Biological Engineering Chongqing Co Ltd
Active IndicationsHemophilia ABlood Coagulation Disorders
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A